Aroa Biosurgery (ASX:ARX) Inventories, Raw Materials & Components: A$1.56 Mil (As of Mar. 2026)


ASX:ARX Aroa Biosurgery Ltd ASX:ARX
63 GF Score
Price A$0.59
GF Value A$0.80
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Aroa Biosurgery Inventories, Raw Materials & Components?

Aroa Biosurgery ASX:ARX +0.85% 63 Inventories, Raw Materials & Components is A$1.56 Mil as of Mar. 2026. GuruFocus rates ASX:ARX with a GF Score™ of 63/100 and a GF Value™ of A$0.80 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Aroa Biosurgery's inventories, raw materials & components for the quarter that ended in Mar. 2026 was A$1.56 Mil.

Aroa Biosurgery's quarterly raw materials declined from Mar. 2025 (A$2.49 Mil) to Sep. 2025 (A$0.00 Mil) but then increased from Sep. 2025 (A$0.00 Mil) to Mar. 2026 (A$1.56 Mil).

Aroa Biosurgery's annual raw materials increased from Mar. 2024 (A$2.27 Mil) to Mar. 2025 (A$2.49 Mil) but then declined from Mar. 2025 (A$2.49 Mil) to Mar. 2026 (A$1.56 Mil).

Aroa Biosurgery Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Aroa Biosurgery's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aroa Biosurgery Inventories, Raw Materials & Components Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1.03 1.79 2.27 2.49 1.56

Aroa Biosurgery Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 0.00 2.49 0.00 1.56
ASX:ARX
63GF Score
Aroa Biosurgery Ltd ASX:ARX
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aroa Biosurgery Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of A$1.56 Mil mean?
Aroa Biosurgery (ASX:ARX) has a Inventories, Raw Materials & Components of A$1.56 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Aroa Biosurgery and its competitors.
Is Aroa Biosurgery's Inventories, Raw Materials & Components too high?
Aroa Biosurgery's current Inventories, Raw Materials & Components is A$1.56 Mil. Overall, Aroa Biosurgery has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aroa Biosurgery's Inventories, Raw Materials & Components compare to ABT and SYK?
Aroa Biosurgery's Inventories, Raw Materials & Components of A$1.56 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Aroa Biosurgery and its competitors. Aroa Biosurgery's current Inventories, Raw Materials & Components is A$1.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aroa Biosurgery stock overvalued right now?
Based on GuruFocus' analysis, Aroa Biosurgery (ASX:ARX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.80, compared to a current price of A$0.59 — trading 26.3% below its estimated fair value. The current Inventories, Raw Materials & Components is A$1.56 Mil. Aroa Biosurgery's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Aroa Biosurgery (ASX:ARX), the current Inventories, Raw Materials & Components is A$1.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aroa Biosurgery (ASX:ARX) Overvalued in 2026?

Based on GuruFocus' analysis, Aroa Biosurgery stock appears to be undervalued. The current stock price of A$0.59 is trading 26.3% below its estimated GF Value™ of A$0.80. GuruFocus considers Aroa Biosurgery to be Modestly Undervalued.

Key valuation signals for ASX:ARX:

  • Inventories, Raw Materials & Components: A$1.56 Mil
  • GF Value™: A$0.80 vs. price of A$0.59 (26.3% below fair value)
  • GF Score™: 63/100 with 1 warning sign

No single metric tells the full story. See the ASX:ARX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aroa Biosurgery Business Description

Other Exchanges AROAF:USA
Address 64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
63GF Score

Get the complete analysis for ASX:ARX

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.59
Price
A$0.80
GF Value